ArticleCureus2024
Intraluminal Insertion of 9-0 Nylon for Postoperative Choroidal Detachment After Preserflo MicroShunt Implantation: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preserflo MicroShunt (PMS) implantation is a minimally invasive surgical procedure for treating glaucoma. Postoperative hypotony, a common complication of PMS implantation, can be prevented and treated with 10-0 nylon insertion. In this report, we present a case of postoperative hypotony following PMS implantation that was treated with intraluminal insertion of 9-0 nylon. A 78-year-old woman with immunoglobulin G4 (IgG4)-related disease and nephrotic syndrome was being treated with oral steroids for more than 15 years. She developed steroid-induced glaucoma in both eyes. At presentation, her intraocular pressures (IOPs) were markedly elevated to nearly 40 mmHg, which caused severe visual dysfunction. We performed PMS implantation in both eyes. The postoperative IOP was maintained at 7-10 mmHg; however, the patient experienced severe choroidal detachment (CD) extending to the posterior pole and shallowing of the anterior chamber in both eyes. After inserting 9-0 nylon into the lumen of the PMS in both eyes, the IOP increased to 25-30 mmHg. Additionally, the CD completely resolved within a month of the procedure. The administration of glaucoma eye drops resulted in a sustained IOP of 15 mmHg. When the 9-0 nylon was removed in the left eye only, the IOP decreased to 8 mmHg, which caused the recurrence and persistence of CD for six months postoperatively. Insertion of 9-0 nylon into the lumen of a PMS may be effective for treating postoperative hypotony; however, future studies are warranted to evaluate the optimal timing for stent removal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.